Cardiovascular safety of hydroxychloroquine: Brief appraisal of data

Cardiovascular safety of hydroxychloroquine: Brief appraisal of data

Hydroxychloroquine (HCQ), widely used in rheumatology since decades and in type 2 diabetes (T2D) since 2014, has garnered special attention in the current pandemic caused by SARS-CoV-2. HCQ appears to be effective in early COVID-19 and prophylaxis, and more studies are ongoing; its efficacy in sever...

Full description

Bibliographic Details
Main Authors: Anil Pareek, Shashank Joshi, Ashok K Das, Ravi Tejraj Mehta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Diabetology
Subjects:
cardiac safety
covid-19
hydroxychloroquine
qt-prolongation
sars-cov-2
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2021;volume=12;issue=2;spage=224;epage=227;aulast=Pareek

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2021;volume=12;issue=2;spage=224;epage=227;aulast=Pareek

Similar Items